使用FAERS,JADER和CVAR数据库分析组胺H1受体对抗剂和广泛痴呆事件之间的关系
Jingjing Kan1, Yechao Chen1, Qiaoling Gu1
1Department of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Expert opinion on drug safety
|June 12, 2025
概括
第一代H1RAs (FG-H1RAs) 与第二代H1RAs (SG-H1RAs) 相比,与痴呆症事件的相关性更强. 这项研究分析了现实世界的数据,发现FG-H1RAs与即时痴呆事件有关,而SG-H1RAs则有延迟发病.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 药品安全 药品安全
背景情况:
- 新出现的证据表明,组胺H1受体对手 (H1RAs) 可能会增加痴呆风险.
- 关于这种关联的现实数据仍然有限,需要进一步调查.
研究的目的:
- 调查第一代H1RAs (FG-H1RAs),第二代H1RAs (SG-H1RAs) 和广泛的痴呆症事件之间的关联.
- 为了比较FG-H1RAs,SG-H1RAs和类药物 (BDs) 之间的痴呆症事件风险信号.
主要方法:
- 利用了来自FAERS,JADER和CVAR数据库 (2004-2024) 的药监数据.
- 使用不成比例分析 (ROR,PRR),发病时间分析,倾向性得分匹配和多变量回归.
- 在不同药物类别中比较痴呆症事件信号.
主要成果:
- FG-H1RAs,SG-H1RAs和BDs与广泛的痴呆事件有显著的关联.
- 与SG-H1RA相比,FG-H1RAs与痴呆症事件的相关性更强 (aROR=0.60).
- FG-H1RAs显示立即发病 (中位数为0天),而SG-H1RAs则延迟发病 (中位数为1天).
结论:
- 这项研究提供了证据,将H1RA治疗与广泛的痴呆症事件联系起来.
- 在FG-H1RAs和SG-H1RAs之间存在关于痴呆事件的信号差异.
- 需要进一步进行大规模的流行病学研究来进行可靠的验证.
相关概念视频
01:19Pharmacovigilance
788
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
788
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
410
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
410
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
01:30Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
01:30Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
01:28Drug-Receptor Interaction: Antagonist
2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K